Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses the concept of an immune reset and what the company is tracking in ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

The most common lilac is Syringa vulgaris, or tree lilac. Native to east Asia and south-east Europe, it was much loved by the Edwardians and was widely grown in suburban gardens before going out of ...

The Grammy-award winner was diagnosed with lupus in 2014 Nathan Vinson is the Weekend Audience Editor for PEOPLE.com, where he oversees PEOPLE's social media channels, newsletters and ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that causes widespread inflammation. It can affect the skin, joints, blood vessels, and multiple organ systems. The exact cause ...

The new data show "robust benefit in lupus and DM,” William Blair analysts ... multiple sclerosis and pemphigus vulgaris (PV) across 50 sites in the U.S. and Europe. The biotech plans to share ...

If you have lupus, you’re at a higher risk for a heart attack or stroke. Up to 74% of people with lupus also have high blood pressure. To lower your likelihood of cardiovascular issues and other ...

Historically, lupus caused people to die young. But today, most people with lupus have a typical life expectancy with treatment. Frequency of flares and complications may influence your outlook ...

Its product pipeline includes CABA-201, a fully human CD19 chimeric antigen receptor to treat systemic lupus erythematosus, rheumatoid arthritis, myositis, and systemic sclerosis; and DSG3-CAART for ...